Programme

BOS Basel 2025 Programme

BOS Basel 2025's scope is primarily development-stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities.

We have a single-track programme consisting of high-quality presentations and drawing from the diverse organisation types in the community including multinational pharmaceutical companies, speciality pharma, SME biotech, CRO/CMO and Consultants. Our programme consists of the following modules:

Outsourcing Business Process
Exploring strategies and processes driving sourcing and procurement of R&D services

Technical Operations
Exploring the technical elements of outsourcing discovery R&D, Drug Substance Outsourcing, Analytical Development Outsourcing, Drug Product Outsourcing for Biologics and Small Molecules.

Outsourcing Case Studies
Building on the Technical Operations sessions, demonstrating outsourcing approaches to real life scenarios.

Share this page

Day 1 - 11th June 2025

Time BOS Basel Programme
08:00 - 09:00
Registration and Partnering (10 min Partnering Slots)
09:00 - 10:30 Outsourcing Process and Strategies
09:00 - 09:30
Trends Shaping the CMC Development for a Diversified Pipeline Portfolio & How CDMOs Can Complement Internal Pharma Capabilities:Speaker to be Confirmed
09:30 - 10:00
Presentation to be Confirmed
10:00 - 10:30
Sourcing and Procurement Toolkit for the Biotech Start Up!
Kirsty Keith, Director of Manufacturing & Outsourcing, Immunocore
photo of Kirsty Keith
About the speaker

Kirsty is Director of Manufacturing and Outsourcing at Immunocore. She is responsible for execution and oversight of outsourced manufacturing of GMP products for clinical trials and commercial supply.

Immunocore is a pioneering T Cell receptor biotechnology company, developing a new generation of transformative medicines addressing unmet needs in cancer, infection and autoimmune disease.

Prior to Immunocore Kirsty spent over 20 years at GSK in small molecule pharmaceutical manufacturing and supply. 15 of those years were spent leading various manufacturing operations, after which she joined GSK's External Supply Organisation to lead the European region. At the beginning of this year Kirsty joined Immunocore to expand her experience in the Biopharmaceuticals arena.

Kirsty is also a certified executive coach and is currently studying for an Executive MBA at Bayes Business School in London.





Full Speaker profile
10:30 - 11:00
Coffee and Partnering
11:00 - 12:00 Outsourcing Case Studies
11:00 - 11:20
Presentation to be Confirmed
11:20 - 11:40
Gold Sponsor Presentation: Siegfried
11:40 - 12:00
Considerations for Selecting a Data Platform to Accelerate Research
Dr Lotti Frauchiger, Head CMC, Molecular Partners
About the speaker


Full Speaker profile
12:00 - 13:30
Lunch and Partnering
13:30 - 15:30 Technical Operations Outsourcing
13:30 - 14:00
Discovery and process development of the new Antibiotic Zosurabalpin : Patrizio Mattei, Distinguished Scientist, Medicinal Chemistry & Ernesto Santandrea, Senior Principal Scientist, F. Hoffmann-La Roche AG
14:00 - 14:30
Presentation to be Confirmed
14:30 - 15:00
Building Robust CDMO Selection Strategies for Biologics Development
Mr Jay Howlett, Director, External Operations, Vir Biotechnology
photo of Jay Howlett
About the speaker

Jay Howlett is the Director of External Operations for the mAb platform at Vir Biotechnology in San Francisco, CA. He has worked in the biotechnology industry for over 20 years in the small biotech, innovator company and contract manufacturing spaces. Previous to Vir, Jay spent 15 years at Genentech/Roche where for 10 years he worked on commercial product transfers (DS, DP and packaging) to support both internal and external needs world-wide and then 5 years in the development space within external manufacturing supporting CMC teams. His contract manufacturing career started at DSM Biologics in Montreal, Canada for early and late stage DS biologics manufacturing. Jay holds an undergraduate degree in chemical engineering from the University of Waterloo (ON, Canada) and a Master of Science in Biology/Biotechnology from Carleton University (ON, Canada).
Full Speaker profile
15:00 - 15:15
Gold Sponsor Presentation
15:15 - 15:30
Gold Sponsor Presentation
15:30 - 16:00
Coffee and Partnering
16:00 - 17:00 Outsourcing Case Studies
16:00 - 16:20
Presentation to be Confirmed
16:20 - 16:40
Gold Sponsor Presentation
16:40 - 17:00
In-house Manufacture or External Sourcing of Gene Editing Reagents to support the Growing Cell and Gene Therapy Business
Dr Ulrich Rümenapp, Senior Program Lead, Bayer AG
photo of Ulrich Rümenapp
About the speaker

Dr. Rümenapp is based in Wuppertal, Germany and working within the Product Supply Biotech organization of Bayer AG, where he is responsible for the transfer of Bayer’s pipeline candidates (antibodies and antibody-drug-conjugates) to external manufacturing partners and regulatory submission and launch preparations.

Prior to working in Development, Dr. Rümenapp was Head of Biotech Projects in Product Supply Biotech at Bayer, where he was responsible for contract manufacturing partnerships in the field of biotechnological drug substances and drug products and interdisciplinary project management with the goal to ensure market supply. Before it was acquired by Bayer, Dr. Rümenapp hold a similar position at Schering AG, and before that, he worked in the Production & Logistics department of Schering, where he was responsible for production aspects of in- and out-licensing deals, due diligences, and product acquisitions of small molecule products and biologics. Dr. Rümenapp studied chemistry and holds a Ph.D. in biosciences. He worked several years in academic research in the field of signal transduction and as an assistant teacher in the field of general pharmacology. Today, Dr. Rümenapp area of expertise is the set-up and management of external relationships for the development and supply of bio-pharmaceutical products. He has more than 20 years of experience in the bio-pharmaceutical industry.To correspond with Dr. Rümenapp, please contact him at [email protected].
Full Speaker profile
17:00 - 19:00
Drinks Reception
Time BOS Basel Programme
08:00 - 09:00
Refreshments and Partnering
09:00 - 11:00 Technical Operations Outsourcing
09:00 - 09:30
Presentation to be Confirmed
09:30 - 10:00
How the Biosecure Act ,and Wider Geopolitical Trends, are Shaping Manufacturing Sourcing Strategies
Dr Carl Hitscherich, Head of External Supply, Alnylam
About the speaker


Full Speaker profile
10:00 - 10:30
Antibody Drug Conjugates: Panorama, perspectives and manufacturing challenges
Dr Olivier Cochet, Head of API Development and CMC Project Leaders, Debiopharm International SA
About the speaker


Full Speaker profile
10:30 - 10:45
Gold Sponsor Presentation
10:45 - 11:00
Gold Sponsor Presentation
11:00 - 11:30
Refreshments and Partnering
11:30 - 12:30 Outsourcing Case Studies
11:30 - 11:50
Agile Outsourcing in the Rare Disease Field: Joenta Case Study
Dr Addy van Dijk, Senior Director CMC Management, Pharming
About the speaker


Full Speaker profile
11:50 - 12:10
Gold Sponsor Presentation
12:10 - 12:30
Presentation to be Confirmed
12:30 - 14:00
Lunch and Partnering
14:00 - 15:00
Presentation to be Confirmed
15:00 - 16:00
Conference Close & Drinks Reception

BIO2BUSINESS LTD. London BioScience Innovation Centre, 2 Royal College Street, London. NW1 0NH.
Contact us by phone on +44 (0)207 691 3568; or by e-mail at [email protected]
Bio2BEvents Home | BOS Media pack for 2024 events | BOS Media pack for 2025 events

Twitter logoLinkedin logo